BNP PARIBAS FINANCIAL MARKETS - SOLENO THERAPEUTICS INC ownership

SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 66 filers reported holding SOLENO THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of SOLENO THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$25,889,000
-17.1%
140,0180.0%0.00%
Q1 2022$31,224,000
-45.7%
140,018
-0.1%
0.00%
Q4 2021$57,477,000
-55.7%
140,189
-0.1%
0.00%
Q3 2021$129,750,000
-18.9%
140,346
+0.1%
0.00%
Q2 2021$159,902,000
-14.5%
140,265
-5.5%
0.00%
Q1 2021$187,019,000
-35.5%
148,428
-1.3%
0.00%
-100.0%
Q4 2020$290,096,000
-24.4%
150,309
-1.7%
0.00%0.0%
Q3 2020$383,686,000
+22.4%
152,863
+8.3%
0.00%0.0%
Q2 2020$313,393,000
-5.9%
141,168
+0.9%
0.00%0.0%
Q1 2020$332,998,000139,9150.00%
Other shareholders
SOLENO THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Abingworth LLP 10,302,602$9,500,0002.16%
Nantahala Capital Management 9,765,129$9,028,0000.28%
ORACLE INVESTMENT MANAGEMENT INC 2,132,000$1,971,0000.24%
Granite Point Capital Management, L.P. 701,838$649,0000.05%
OPPENHEIMER & CO INC 639,140$591,0000.01%
Ikarian Capital, LLC 121,694$112,0000.01%
Warberg Asset Management LLC 30,000$28,0000.01%
Levy Wealth Management Group, LLC 10,000$9,0000.01%
Ergoteles LLC 74,525$69,0000.00%
TWO SIGMA ADVISERS, LP 744,000$688,0000.00%
View complete list of SOLENO THERAPEUTICS INC shareholders